Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, New Taipei 220, Taiwan.
Department of Surgery, Far Eastern Memorial Hospital, Pan-Chiao, New Taipei 220, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Chung-Li, Taoyuan 320, Taiwan.
J Formos Med Assoc. 2023 May;122(5):419-426. doi: 10.1016/j.jfma.2022.10.003. Epub 2022 Oct 28.
BACKGROUND/PURPOSE: Periodical replacement of venous Hickman catheters is required for the nutritional care of patients with intestinal failure. The conventional de novo operation (DN-OP) involves inserting the catheter into a new venous tract in each replacement; however, this could result in fast consumption of functional central vessels in patients with intestinal failure. Recently, same-route operation (SR-OP) has been adopted as an alternative approach for retaining venous access.
We conducted a retrospective study to compare the efficacy of Hickman catheters and the survival of venous vessels using two different operative strategies.
Overall, 181 catheters were inserted, 109 using DN-OP and 72 using SR-OP. The mean catheter duration was 11.9 ± 8.8 months in the DN-OP group and 10.5 ± 5.6 months in the SR-OP group; the infection rate was 0.74 in the DN-OP group and 0.44 in the SR-OP group. The vein accesses used in these insertions (n = 113) were classified: the DN-vein group for veins accessed only by DN-OP (n = 75) and the SR-vein group for veins accessed by an initial DN-OP and subsequent SR-OPs (n = 38). Mean working duration per vein access was 12.3 ± 10.1 months in the DN-vein group and 28.2 ± 14.8 months in the SR-vein group (p < 0.001); mean infection-free duration was 11.4 ± 10.1 months in the DN-vein group and 27.7 ± 15.3 months in the SR-vein group (p < 0.001).
Application of SR-OP in Hickman catheter replacement significantly extended the working duration of venous access by re-using the same venous route without compromising catheter efficacy in patients with IF having poor venous access.
背景/目的:肠衰竭患者的营养支持需要定期更换静脉 Hickman 导管。传统的从头(de novo,DN)手术需要在每次更换时将导管插入新的静脉通路;然而,这可能导致肠衰竭患者的功能性中央血管快速消耗。最近,同路手术(same-route,SR)已被采用作为保留静脉通路的替代方法。
我们进行了一项回顾性研究,比较了两种不同手术策略下 Hickman 导管的效果和静脉血管的存活率。
总共插入了 181 根导管,109 根采用 DN-OP,72 根采用 SR-OP。DN-OP 组导管持续时间为 11.9±8.8 个月,SR-OP 组为 10.5±5.6 个月;DN-OP 组感染率为 0.74,SR-OP 组为 0.44。这些插入术使用的静脉通路(n=113)分为:仅通过 DN-OP 进入的 DN-静脉组(n=75)和初始通过 DN-OP 进入、随后通过 SR-OP 进入的 SR-静脉组(n=38)。DN-静脉组每根静脉通路的工作持续时间为 12.3±10.1 个月,SR-静脉组为 28.2±14.8 个月(p<0.001);DN-静脉组无感染持续时间为 11.4±10.1 个月,SR-静脉组为 27.7±15.3 个月(p<0.001)。
在肠衰竭患者静脉通路较差的情况下,SR-OP 在 Hickman 导管更换中的应用通过重新使用相同的静脉途径,在不影响导管效果的情况下,显著延长了静脉通路的工作时间。